Cryoport, Inc. CYRX Cash Flow

Cryoport, inc. (CYRX)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Cash Flows From Operating Activities:
Net loss
-3,942	-947	-12,468	-2,528	-2,386	-2,258	-2,143	-2,470	-2,682	-2,269	-1,979	-1,860	-1,789	-4,283	-2,184	-3,934	-2,710	-2,760	-2,425	-1,924	-1,937	-1,407	-1,384	-2,297	-1,441	-1,840	-14,959	-1,323	-1,716	-1,567	-1,552	-1,545	-1,669	-2,079	-2,030	-2,053	-1,857	-1,456	-1,509	-1,328
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
824	825	792	496	300	264	214	191	187	172	184	176	131	102	100	97	72	72	48	45	42	50	50	55	53	79	89	89	86	90	121	95	92	88	83	78	69	66	56	52
Amortization of debt discount
0	241	15	15	15	0	0	0	0	0	0	0	6	6	6	6	66	65	65	286	220	38	0	1,110	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized gain on investments in equity securities
144	-13	-163	43	31	-16	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized loss on investments in equity securities
793	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized gain on available-for-sale investments
10	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
1,620	-	-	-	1,413	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	138	25	464	50	8	0	0	8	26	42	57	70	136	135	128	121
Stock-based compensation expense
-	-	-	-	-	-	-	1,445	1,049	1,017	964	794	770	780	799	749	788	939	637	480	316	210	187	167	168	178	174	157	-	-	-	-	-	-	-	-	-	-	-	-
Warrant inducement and repricing expense
-	-	-	-	-	0	0	0	899	0	0	0	0	2,265	0	1,929	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	1	0	18	-	-	-	-	10	60	14	34	-227	33	126	116
Fair value of stock options and warrants issued to employees, directors and consultants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-239	-168	-80	-31	-157	-542	171	-	-51	-187	-152
Change in fair value of derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6	14	19	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment
-80	-115	-58	-52	-47	-225	-109	-41	-20	-109	-26	-32	-17	-21	-7	-9	-131	-4	-32	0	-10	-3	-0	-1	-10	-3	-2	0	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debt
3	0	0	42	0	-	-	-	-	-	-	-	-	9	25	7	2	1	30	3	2	0	5	-5	24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-954	-398	1,401	1,929	664	318	-389	1,268	760	161	223	-215	272	205	10	1	406	-84	-23	171	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of cryogenic shippers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	0	-0	-2
Interest accrued on restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0
Accounts receivable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-78	-28	-94	248	29	140	15	30	25	-1	62	-27	35	20	19	-23	26	-48
Inventories
-9	123	44	79	6	90	33	-24	7	24	17	1	-18	7	-1	13	55	-26	6	35	2	8	20	8	-0	-13	-9	13	-16	-0	8	-4	4	4	-2	0	-	-	-	-
Prepaid expenses and other current assets
-94	140	429	-215	-10	-118	379	-50	25	284	-44	-12	34	-319	317	40	-40	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposits
46	30	-0	56	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in operating lease right-of-use assets and lease liabilities
-6	-3	-5	5	9	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	342	16	-	-	66	25	-	-	-5	13	3	13	-1	10	-25	18	1	-28	-18	-30	-60	-64	46	149	-38	-1
Accounts payable and other accrued expenses
65	-697	-444	1,053	659	-223	-333	852	108	-77	-4	-123	329	176	72	-160	-37	453	144	-247	54	10	164	-20	-351	350	-167	-54	142	223	47	30	-400	159	142	35	50	-75	120	-205
Accrued compensation and related expenses
767	336	32	-219	491	377	-18	-171	149	296	30	184	-5	50	-8	-131	131	10	-55	-285	108	67	47	47	62	49	61	63	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-26	-	-	-	-28	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liability
9	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	3	-3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued compensation and related expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16	107	317	-143	121	-128	463	-18	-129	-9
Accrued interest
-	-	-	-	-	-	-	-	-	0	0	0	-1	4	-2	9	6	0	-18	-1	21	10	7	18	22	8	46	30	19	10	10	-1	24	11	11	12	13	14	14	15
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,534	-1,449	-1,969	-1,393	-1,068	-1,874	-1,292	-1,060	-857	-917	-1,221	-841	-1,146	-1,170	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities
1,059	741	-813	-1,061	-189	-359	-664	-1,265	-1,063	-1,220	-965	-568	-829	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,022	-1,231	-1,424	-2,106	-1,482	-1,644	-1,546	-1,172	-1,406	-985	-1,247
Cash Flows From Investing Activities:
Purchases of property and equipment
596	1,146	1,610	1,457	1,121	1,081	863	699	269	485	207	391	631	396	67	193	405	378	225	109	2	0	67	0	-0	2	6	131	85	24	2	43	18	121	78	44	42	27	60	210
Purchases of short-term investments
16,195	151	37,024	1,010	5,010	8	9,915	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales/maturities of short-term investments
16,278	2,000	1,995	1,500	500	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Patent and trademark costs
29	25	5	22	20	12	7	11	15	34	26	14	10	0	5	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	45	54	25	28	21	29	44
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-72	-193	-405	-378	-225	-109	-2	0	-67	0	0	-2	-6	-131	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-542	789	-36,645	-21,419	-5,651	-1,102	-10,785	-711	-284	-519	-234	-405	-641	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24	-2	-43	-18	-166	-132	-69	-70	-49	-89	-255
Cash Flows From Financing Activities:
Proceeds from the issuance of Class A and Class B convertible preferred stock, net of offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,804	1,140	882	780	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options and warrants
2,877	1,078	1,412	1,555	1,315	417	1,950	2,993	658	1,384	3,742	25	0	0	0	0	0	0	0	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of costs
-	-	-	-	-	-	-	-	-	-11,405	0	-165	11,571	0	0	0	0	2,041	0	3,896	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the rights offering, net of offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	8	186	-1,185	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of related party notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24	16	24	24	24	30	70	30	30	30
Proceeds from tender offer, net of offering costs
-	-	-	-	-	0	0	0	4,641	0	0	0	0	-	-46	2,290	-	-	0	0	80	0	0	11	146	80	0	100	0	0	0	0	-0	115	324	132	-	-	-	-
Proceeds from issuance of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,352	591	1,657	958	1,294	0	0	0	-	-	-	-	-	-	-	-
Repayment of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	741	173	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	82	496	600	600	576	-	-	-	-
Payment of deferred financing costs
0	-19	0	0	19	288	0	0	0	-	-	-	-	-	-	0	-	-	-	89	-	-	-	0	104	115	175	67	78	5	43	78	0	0	27	130	-	-	-	-
Repayment of finance lease liabilities
14	5	5	5	5	14	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of related-party notes payable
-	-	-	-	-	-	-	-	-	0	0	563	92	98	128	98	80	40	60	112	0	0	0	50	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
2,863	1,092	1,410	70,356	1,290	24,936	5,301	2,993	5,300	1,384	3,742	-704	11,479	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-37	-67	-177	3,947	-508	-325	-605	7,810	421	2,723	-30
Effect of exchange rates on cash and cash equivalents
7	26	-8	-5	-3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
3,387	2,649	-36,057	47,870	-4,555	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rates on cash and cash equivalents
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of related-party notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	56	24	24	24	24	24	24	24	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-360	3,376	-80	-40	5,967	2,964	1,925	1,731	858	717	1,370	531	1,458	966	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,967	1,733	-2,454	-1,812	4,673	980	631	670	-67	-199	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	3,951	-355	2,542	-1,678	10,008	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-335	-22	-1,084	-1,301	-1,645	1,821	-2,157	-2,103	-2,221	6,567	-1,034	1,648	-1,532
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	3	12	0	24	38	50	22	1	12	2
Cash paid for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1	0	0	0	1
Supplemental Disclosure of Non-Cash Financing Activities:
Net unrealized gain on available-for-sale securities
470	-	-	28	30	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of realized gain on available-for-sale debt securities to earnings
0	1	8	9	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of equipment through capital lease obligations
202	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fixed assets included in accounts payable and accrued liabilities
608	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in net unrealized gain on available-for-sale securities
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of realized gain on available-for-sale debt securities to earnings
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs included in additional paid-in capital and accounts payable and other accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	165	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cumulative undeclared preferred dividends recorded upon conversion of Class A convertible preferred stock and Class B convertible preferred stock into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,068	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Release of restricted cash for repayment of convertible debentures payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	251	-	-	0	0	-	-	-	-
Estimated relative fair value of warrants issued in connection with convertible bridge notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	222	56	92	106	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs included in additional paid-in capital and accounts payable and other accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	0	0	9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for accrued board of director compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred financing costs in connection with equity financing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
Fair value of shares issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23
Offering costs in connection with convertible preferred stock included in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-27	27	-	-	-	-
Deferred offering costs in connection with secondary public offering included in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-42	70	-	-	0	0	-	-	-	-	-	-	-	-
Accretion of convertible preferred stock beneficial conversion feature and relative fair value of warrants issued in connection with the convertible preferred stock units to accumulated deficit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	4,474	1,902	492	1,727	741	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of bridge notes payable and accrued interest into common stock units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	150	3,977	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of convertible debentures payable and accrued interest into convertible preferred stock units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,766	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cashless exercise of warrants and stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-